These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 20666768)
1. Photodynamic therapy for actinic keratoses: time to re-evaluate? Morton CA Br J Dermatol; 2010 Aug; 163(2):236-7. PubMed ID: 20666768 [No Abstract] [Full Text] [Related]
2. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation. Kolde G; Rowe E; Meffert H Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095 [No Abstract] [Full Text] [Related]
3. Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses. Bissonnette R; Bolduc C; Maari C; Nigen S J Am Acad Dermatol; 2012 Dec; 67(6):1386-7. PubMed ID: 23158619 [No Abstract] [Full Text] [Related]
5. Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses. Neittaanmäki-Perttu N; Grönroos M; Tani T; Snellman E Acta Derm Venereol; 2016 Jun; 96(5):712-3. PubMed ID: 26806126 [No Abstract] [Full Text] [Related]
6. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis. Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784 [TBL] [Abstract][Full Text] [Related]
8. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation. Downs AM; Bower CB; Oliver DA; Stone CA Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229 [No Abstract] [Full Text] [Related]
9. Photodynamic therapy for actinic keratoses: aren't we there yet? Lui H JAMA Dermatol; 2014 Dec; 150(12):1289. PubMed ID: 25162746 [No Abstract] [Full Text] [Related]
10. Daylight photodynamic therapy in private practice in Switzerland: gain without pain. Braathen LR Acta Derm Venereol; 2012 Nov; 92(6):652-3. PubMed ID: 22930201 [No Abstract] [Full Text] [Related]
12. Photodynamic therapy with delta-aminolevulinic acid and light-emitting diodes in actinic keratosis. Ritter CG; Kuhl IC; Lenhardt C; Weissbluth ML; Bakos RM An Bras Dermatol; 2010; 85(5):639-45. PubMed ID: 21152788 [TBL] [Abstract][Full Text] [Related]
13. Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms. Fai D; Fai C; Cassano N; Vena GA G Ital Dermatol Venereol; 2019 Oct; 154(5):603-605. PubMed ID: 29485253 [No Abstract] [Full Text] [Related]
14. Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses. Neittaanmäki-Perttu N; Karppinen TT; Tani T; Snellman E; Grönroos M Acta Derm Venereol; 2017 Jan; 97(1):120-121. PubMed ID: 27304514 [No Abstract] [Full Text] [Related]
15. 5-Aminolevulinic acid photodynamic therapy with and without Er:YAG laser for actinic keratosis: Changes in immune infiltration. Gellén E; Fidrus E; Janka E; Kollár S; Paragh G; Emri G; Remenyik É Photodiagnosis Photodyn Ther; 2019 Jun; 26():270-276. PubMed ID: 30986538 [TBL] [Abstract][Full Text] [Related]
16. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis. Martin G J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547 [TBL] [Abstract][Full Text] [Related]
17. Severe cutaneous reaction to photodynamic therapy with blue light. Moore MM; Reyna C; Hope RH J Drugs Dermatol; 2011 Sep; 10(9):1057-8. PubMed ID: 22052277 [TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp. Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261 [No Abstract] [Full Text] [Related]
19. Daylight photodynamic therapy: the Southern California experience. Lane KL; Hovenic W; Ball K; Zachary CB Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047 [TBL] [Abstract][Full Text] [Related]
20. [Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis]. Fernández-Guarino M; Harto A; Jaén P Actas Dermosifiliogr; 2010 May; 101(4):315-22. PubMed ID: 20487686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]